🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Advanced Enzyme Technologies Limited ADVENZYMES NSEINFRA

Basic Materials · Specialty Chemicals · India
https://www.advancedenzymes.com
Company Profile ↓
₹330.25
-0.38% 1Y
Mkt Cap₹3,696.38 Cr
P/E28.20
P/B2.27
Div. Yield0.77%
52W High₹392.10
52W Low₹255.30
Book Value₹145.81
EPS (TTM)₹11.71

Company Overview

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It also provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is headquartered in Thane, India.

Why Investors Should Care

Consistent Profit Growth

Net profit has compounded at 16.9% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 11.3% CAGR over the past five years.

Healthy Margins

Maintains a net profit margin of 22.7%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹744.95 Cr (+17.0% YoY); net profit ₹168.72 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +17.0%, earnings +28.7%.
  • 5-Year Trend Long-term compounding — revenue CAGR 11.3%, profit CAGR 16.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:11.29%
1 Year:17.04%

Compounded Profit Growth

5 Years:16.89%
1 Year:28.68%

Stock Price Performance

1 Year:-0.38%
6 Months:+9.10%
3 Months:+7.87%
1 Month:-10.10%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 55% of range
₹255.30 ₹392.10
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMAAbove
  • RSI (14)42.75 · Neutral
Price Performance
1M-10.10%
3M+7.87%
6M+9.10%
1Y-0.38%
Valuation vs Sector

P/E of 28.20 is above the sector median of 27.45 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Excellent profit margin of 22.7%.
  • Compounding revenue at 11.3% over 5 years.
  • Profit CAGR of 16.9% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
28.20
Industry PE
27.45
Forward P/E
17.95
PEG Ratio
-
Book Value
₹145.81
Price to Book
2.27
P/S
4.98
EV/EBITDA
14.23
Dividend Yield
0.77%

Growth (CAGR)

Revenue 5Y
11.29%
Profit 5Y
16.89%
Revenue (YoY)
17.04%
Earnings (YoY)
28.68%

Profitability & Returns

ROCE
13.58%
ROE
10.34%
ROA
9.18%
Profit Margin
22.65%
Op Margin
25.78%
Gross Margin
72.22%
EPS (Latest Qtr)
₹3.84
EPS (TTM)
₹11.71

Balance Sheet & Liquidity

Debt/Equity
1.96
Quick Ratio
8.12
Current Ratio
9.78
Debt
₹32.01 Cr
Total Assets
₹1,838.76 Cr
Current Assets
₹1,043.57 Cr
Working Capital
₹936.85 Cr

Ownership

Promoter Holding
55.46%
Chg in Prom Hold
-0.02%
FII / Inst Holding
18.68%
Chg in FII Hold
-0.01%

Financial Snapshot

Enterprise Value
₹3,696.38 Cr
Total Revenue (TTM)
₹744.95 Cr
EBITDA
₹275.26 Cr
Free Cash Flow
₹104.40 Cr
Operating Cash Flow
₹156.78 Cr
Shares Outstanding
₹11.19 Cr
Gross Margin
72.22%
Payout Ratio
34.53%

Peer comparison

Peer companies in the same sector (Basic Materials).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 ADVENZYMES Advanced Enzyme Technologies Limited NSEINFRA 330.25 28.20 ₹3,696.38 Cr 0.77% 13.58% 10.34% 11.29% 16.89%
2 ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA 11,659.00 56.84 ₹3.44 L Cr 0.66% 11.90% 10.66% 12.40% 17.26%
3 JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA 1,244.70 86.92 ₹3.04 L Cr 0.57% 18.75% 22.30% 3.61% 75.28%
4 ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA 2,675.50 59.31 ₹2.57 L Cr 1.03% 24.41% 20.24% 1.10% 1.75%
5 TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA 187.67 21.70 ₹2.34 L Cr 2.09% 11.32% 10.56% -1.59% 7.21%
6 HINDZINC Hindustan Zinc Limited NSEINFRA 532.50 16.26 ₹2.25 L Cr 3.91% 61.97% 61.13% 5.61% 9.58%
7 HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA 963.55 16.01 ₹2.17 L Cr 0.52% 9.42% 9.80% 7.10% 9.87%
8 GRASIM Grasim Industries Limited NIFTY50NSEINFRA 3,133.10 56.45 ₹2.13 L Cr 0.31% 4.00% 4.80% 14.63% -10.06%
9 VAML Vedanta Aluminium Metal Limited NSEINFRA 452.95 inf ₹1.77 L Cr 0.00% 41.97% 49.39% - -46.32%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 139.00 Cr147.00 Cr158.00 Cr161.00 Cr158.00 Cr155.00 Cr146.00 Cr169.00 Cr167.18 Cr185.91 Cr184.53 Cr171.95 Cr203.37 Cr
Cost of Revenue --------46.09 Cr50.05 Cr44.57 Cr41.41 Cr56.93 Cr
Gross Profit --------121.09 Cr135.87 Cr139.96 Cr130.54 Cr146.44 Cr
Operating Expenses 95.00 Cr103.00 Cr107.00 Cr107.00 Cr102.00 Cr103.00 Cr104.00 Cr114.00 Cr85.57 Cr89.05 Cr89.98 Cr91.40 Cr93.40 Cr
Operating Income 36.00 Cr35.00 Cr42.00 Cr45.00 Cr46.00 Cr42.00 Cr33.00 Cr46.00 Cr35.53 Cr46.81 Cr49.98 Cr39.14 Cr53.04 Cr
EBITDA 44.00 Cr44.00 Cr51.00 Cr54.00 Cr55.00 Cr51.00 Cr42.00 Cr55.00 Cr54.35 Cr65.28 Cr70.34 Cr69.06 Cr70.57 Cr
Interest Expense 1.00 Cr1.00 Cr1.00 Cr1.00 Cr1.00 Cr1.00 Cr1.00 Cr1.00 Cr81.10 L76.40 L72.20 L56.80 L57.30 L
Pretax Income 42.00 Cr41.00 Cr48.00 Cr59.00 Cr40.00 Cr49.00 Cr42.00 Cr53.00 Cr43.46 Cr54.90 Cr59.54 Cr58.29 Cr59.80 Cr
Tax Provision 10.08 Cr11.89 Cr12.96 Cr16.52 Cr10.00 Cr13.72 Cr8.82 Cr14.31 Cr16.73 Cr14.46 Cr14.81 Cr15.11 Cr14.55 Cr
Net Income 32.00 Cr29.00 Cr35.00 Cr42.00 Cr30.00 Cr35.00 Cr33.00 Cr39.00 Cr26.48 Cr39.93 Cr43.33 Cr42.50 Cr42.96 Cr
Diluted EPS 2.872.583.083.742.533.052.943.372.373.573.873.793.84

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 222.00 Cr293.00 Cr329.00 Cr391.00 Cr420.00 Cr444.00 Cr502.00 Cr-540.38 Cr623.48 Cr636.51 Cr744.95 Cr
Cost of Revenue --------142.77 Cr159.41 Cr164.84 Cr206.97 Cr
Gross Profit --------397.61 Cr464.07 Cr471.67 Cr537.98 Cr
Operating Expenses 131.00 Cr155.00 Cr177.00 Cr226.00 Cr236.00 Cr241.00 Cr269.00 Cr-259.32 Cr291.24 Cr311.09 Cr345.91 Cr
Operating Income 82.00 Cr129.00 Cr139.00 Cr147.00 Cr163.00 Cr177.00 Cr204.00 Cr-138.30 Cr172.83 Cr160.58 Cr192.07 Cr
EBITDA 91.00 Cr138.00 Cr152.00 Cr165.00 Cr184.00 Cr203.00 Cr232.00 Cr-177.84 Cr225.99 Cr227.48 Cr275.26 Cr
Interest Expense 9.00 Cr8.00 Cr4.00 Cr9.00 Cr5.00 Cr4.00 Cr3.00 Cr-2.42 Cr2.93 Cr3.56 Cr2.63 Cr
Pretax Income 74.00 Cr118.00 Cr137.00 Cr139.00 Cr162.00 Cr179.00 Cr210.00 Cr-140.39 Cr187.82 Cr187.36 Cr232.54 Cr
Tax Provision 22.94 Cr41.30 Cr43.84 Cr45.87 Cr45.36 Cr46.54 Cr58.80 Cr-36.52 Cr50.87 Cr53.39 Cr58.93 Cr
Net Income 51.00 Cr77.00 Cr93.00 Cr94.00 Cr116.00 Cr133.00 Cr151.00 Cr-105.64 Cr133.31 Cr131.12 Cr168.72 Cr
Diluted EPS 4.606.978.208.079.9511.5813.0910.689.4511.9211.71-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 417.00 Cr450.00 Cr583.00 Cr727.00 Cr805.00 Cr971.00 Cr1,146.00 Cr-1,421.85 Cr1,535.46 Cr1,621.35 Cr1,838.76 Cr
Current Assets --------721.06 Cr809.47 Cr879.87 Cr1,043.57 Cr
Cash & Equivalents --------96.42 Cr113.75 Cr94.22 Cr108.75 Cr
Inventory --------123.99 Cr148.46 Cr157.31 Cr177.28 Cr
Receivables --------100.34 Cr98.57 Cr115.40 Cr145.02 Cr
Total Liabilities --------137.68 Cr164.38 Cr152.68 Cr155.64 Cr
Current Liabilities --------77.57 Cr106.36 Cr96.25 Cr106.72 Cr
Long Term Debt --------7.80 Cr6.96 Cr9.18 Cr7.89 Cr
Total Debt 115.00 Cr101.00 Cr54.00 Cr67.00 Cr35.00 Cr28.00 Cr23.00 Cr-33.50 Cr47.31 Cr39.35 Cr32.01 Cr
Total Equity 210.00 Cr278.00 Cr464.00 Cr559.00 Cr679.00 Cr839.00 Cr970.00 Cr-1,235.07 Cr1,324.13 Cr1,420.86 Cr1,631.96 Cr
Shares Outstanding --------11.18 Cr11.18 Cr11.19 Cr11.19 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 54.00 Cr93.00 Cr107.00 Cr116.00 Cr129.00 Cr141.00 Cr163.00 Cr-140.36 Cr141.37 Cr142.50 Cr156.78 Cr
Investing Cash Flow -15.00 Cr-10.00 Cr-60.00 Cr-60.00 Cr-124.00 Cr-43.00 Cr-27.00 Cr--298.18 Cr-64.65 Cr-89.10 Cr-74.13 Cr
Financing Cash Flow -36.00 Cr-63.00 Cr-65.00 Cr-2.00 Cr-43.00 Cr-39.00 Cr-26.00 Cr--25.80 Cr-59.24 Cr-72.54 Cr-70.37 Cr
Capital Expenditure -12.00 Cr-5.00 Cr-10.00 Cr-11.00 Cr-13.00 Cr-51.00 Cr-20.00 Cr--38.18 Cr-47.31 Cr-34.78 Cr-52.38 Cr
Free Cash Flow 42.00 Cr88.00 Cr97.00 Cr105.00 Cr116.00 Cr90.00 Cr143.00 Cr-102.18 Cr94.06 Cr107.72 Cr104.40 Cr
Net Change in Cash 2.00 Cr21.00 Cr-18.00 Cr54.00 Cr-38.00 Cr60.00 Cr109.00 Cr--183.62 Cr17.48 Cr-19.15 Cr12.28 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % --------73.6%74.4%74.1%72.2%
Operating Margin % 36.9%44.0%42.2%37.6%38.8%39.9%40.6%-25.6%27.7%25.2%25.8%
Net Margin % 23.0%26.3%28.3%24.0%27.6%30.0%30.1%-19.5%21.4%20.6%22.6%
ROE % 24.3%27.7%20.0%16.8%17.1%15.9%15.6%-8.6%10.1%9.2%10.3%
ROCE % --------10.3%12.1%10.5%11.1%

Shareholding Pattern

Insiders
55.46%
Institutions
18.68%
Public Float
41.94%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ADVENZYMES

Google News Wed, 15 Jul 2026

Impressive Earnings May Not Tell The Whole Story For Advanced Enzyme Technologies (NSE:ADVENZYMES) - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi8gFBVV95cUxNaUo4Z1ExeWNvWVJldEpWSFVyZkhPWExZQmRqOTQ0ZE9yQkxIVTA1SGxSX05LeDdMaE0yOHM5bHVsRkJaeDZXMWs2dFZzU1JuWWlNX2c3eWQ2TGp4XzdPd3FtdFhXRmpkWTFXSEc1d3k1MjY5Tjk1ckhQajFfd0tPSzVfZW9MVEdraldvN0…

Google News Fri, 19 Jun 2026

Advanced Enzyme Technologies (NSEI:ADVENZYMES) Stock Draws Fresh Price Target Split Ahead Of Results - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOQ2hEUmpWTVk5SFZYbGVHRFdPWFdvaXIzRlE3TUdjeVBqX2VPX0w1Ymt2SHNuVUZ4V2RlQWJxQXJmRFBlcnFvakJHZmd3ZURpNThxR0hSaVZXOFdzYVpnclJxU1hLRU1ib2pEblJPRmR5SFcyd1Z5dzNmLXBvMlZpNGxNU2dQUVlNSUNhNl…

Google News Sun, 05 Apr 2026

How The Narrative On Advanced Enzyme Technologies (NSEI:ADVENZYMES) Is Shifting Around The ₹370 Fair Value - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPSmVEekZReHVkN01DTEhXU0VHSllYMVJzVFVHOE1sai1wZXVOLWs0Y3dobTU2QkIzbi0yZDBVV1laUGF3TjkyQlN5eDh1bWxYTFY1TDVkYnZTb2tvbUU3VkpnV1JWM0l3bEpGYXIyS2pmR1c0UE1JSEdzRmRCRG5OT0lnMXdiUmJQbXFGT3…

Google News ue, 30 Jun 2026

If EPS Growth Is Important To You, Advanced Enzyme Technologies (NSE:ADVENZYMES) Presents An Opportunity - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxNd3V6MkxtX1NibmRrS2dzTFQyZ2ljYnZ0U0FnNHBKd0g4LVpvWGRYQmMzWTJrcXJpaUdWQmh3TUduMUZWTlF2WkdIRUY3N1o2NGVoMHM4cEE1aDRUYVJSWFozczBnZ1E0NXF5ZXNxN3FPbjdHbzhZX3hRQ1BZX0JjSkI3WmVRSjQ2RlJWcD…

Google News Sat, 09 May 2026

Advanced Enzyme Technologies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 - marketscreener.com

<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxQT29jeW9JNnF2cmlMRUs5UUFHSEdjN1JyZE11WmpJaXl1NmVQa0drZDdTaEE3TWR5RUJsRDZmNy13MklLMG9KYktsTGtvUnczbjRQOHJySjZTT1dSRlcxaENsTV90V0h4R0dHU3h2RkIzLVhUU0t1Vl9ReGtWQzhxME8xcFJhYW9HcnhLZn…

Google News Sat, 03 Jan 2026

Advanced Enzyme Technologies Ltd. Share Price Live Today - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPS0hKWHNHWGtzY3pBbUV3SFJTMWlfOV8yT1pkQmxaUzVSekpIaWJqb1JJc0pfTmJuWnBlZWU5alYtN1BJYlp6SEJta3FMOFE3SV9RR19haFV3MFBNWVRmQXR2VFMzajZyd1FkNDViSGZYNFlDUG1NTXZTT0VoM3kxXzBxdmFwbTI3eG00cX…

ADVENZYMES — Frequently Asked Questions

What is the current share price of Advanced Enzyme Technologies Limited (ADVENZYMES)?

As of 2026-07-15 09:52 IST, Advanced Enzyme Technologies Limited (ADVENZYMES) trades at ₹330.25 on NSE. Its 52-week range is ₹255.30 to ₹392.10.

What is the market capitalisation of ADVENZYMES?

Advanced Enzyme Technologies Limited (ADVENZYMES) has a market capitalisation of ₹3,696.38 Cr on NSE.

What is the P/E ratio of ADVENZYMES?

ADVENZYMES trades at a trailing price-to-earnings (P/E) ratio of 28.20. The industry average P/E is 27.45. Its price-to-book (P/B) ratio is 2.27.

Does ADVENZYMES pay a dividend?

Advanced Enzyme Technologies Limited (ADVENZYMES) currently offers a dividend yield of 0.77%.

What is the return on equity (ROE) of ADVENZYMES?

ADVENZYMES has a return on equity (ROE) of 10.34%. Its return on capital employed (ROCE) is 13.58%.

Is ADVENZYMES a good stock to buy?

This page provides a data-driven analysis of Advanced Enzyme Technologies Limited (ADVENZYMES), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Basic Materials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space